Fourth quarter of 2002
US
NGOs Target COGEMA’s Environmental Record
A recent publication from the Safe Energy Communication
Council (SECC) compiles “incidents of concern of activities involving
COGEMA that jeopardize human health and the environment” (1)
and cases of COGEMA unconformity with international regulations.
WISE-Paris, 8 October 2002
[Posted 10/10/2002]
The 12-pages SECC paper entitled “The
COGEMA File” accuses the company to ignore international
agreements in order to develop its industrial activities. COGEMA’s
rather original interpretation as “zero impact”
approach of the “zero release” policy outlined
in 1992 by the OSPAR Convention for the Protection of the Marine Environment
of the North-East Atlantic, is described as unacceptable from a US regulatory
standpoint.
The author argues that COGEMA denies or rejects
scientific findings on health and environmental impacts of its reprocessing
activities such as childhood leukemia studies (2)
or the WISE-Paris STOA Report. (3) “The
COGEMA File” complains about “the culture of secrecy”
of the company and its lack of respect with regard to French regulations.
Various cases are discussed such as the delayed closure of the Cadarache
MOX plant, MOX quality-control problems or the import of foreign nuclear
waste to La Hague.
SECC states in the report, that even if COGEMA itself
is not implicated in the US military plutonium disposition program,
its “culture of secrecy, disregards for international laws
and scientific standards and a record of contamination, flawed quality-control,
dumping, leaks and fines is likely to permeate” its US subsidiary,
COGEMA Inc., which is in charge of the US MOX program development. SECC
concludes that the US Department of Energy should not award contracts
to COGEMA.
Notes:
- SECC, “The COGEMA File”, 1st
October 2002, http://www.safeenergy.org/pr100102.htm
- “The COGEMA File” citations:
- D. Pobel, J-F. Viel: “Case-control study of leukemia among
young people near La Hague nuclear reprocessing plant: the environmental
hypothesis revisited”, British Medical Journal, No. 7074
Vol. 314, January 11, 1997
- A-V Guizard, O. Boutou, D. Pottier, X. Troussard, D. Pheby, G. Launoy,
R. Slama, A. Spira and ARKM; “The incidence of childhood
leukemia around the La Hague nuclear waste reprocessing plant (France):
a survey for the years 1978-1998”, Journal of Epidemiology
and Community Health, July 2001, Vol. 55, pp. 469-74
- M. Schneider, et al.; “Possible Toxic
Effects from the Nuclear Reprocessing Plants at Sellafield (UK) and
Cap de La Hague (France)”, commissioned by the Scientific
and Technological Options Assessment Office (STOA) of the European
Parliament, WISE-Paris, October 2001, http://www.wise-paris.org/english/reports/STOAFinalStudyEN.pdf
Back
to contents
|